176 related articles for article (PubMed ID: 29552778)
21. [Expression of full-length spleen tyrosine kinase in the oral squamous cell carcinoma and its relationship with tumor invasion and metastasis].
Wang Z; Chen J; Chu W; Da M; Ma L; Wu M; Zhong Y; Wang Z; Song X; Wu Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Oct; 33(5):519-23. PubMed ID: 26688948
[TBL] [Abstract][Full Text] [Related]
22. Expression of T-lymphoma invasion and metastasis factor on the occurrence of oral squamous cell carcinoma.
Song B; Wang LF; Fan XH; Zuo JH; Huang YM
J Biol Regul Homeost Agents; 2017; 31(2):289-295. PubMed ID: 28685528
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.
Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z
PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884
[TBL] [Abstract][Full Text] [Related]
24. Semaphorin 4A restricts tumor progression by inhibiting angiogenesis of oral squamous cell carcinoma cells.
Liu XQ; Yao Y; Mu JW; Yang FY
Tissue Cell; 2021 Apr; 69():101485. PubMed ID: 33460983
[TBL] [Abstract][Full Text] [Related]
25. Circ-ABCB10 accelerates the malignant progression of oral squamous cell carcinoma by absorbing miRNA-145-5p.
Chen F; Li XH; Liu C; Zhang Y; Wang RJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):681-690. PubMed ID: 32016969
[TBL] [Abstract][Full Text] [Related]
26. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
[TBL] [Abstract][Full Text] [Related]
27. Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.
Sasabe E; Tomomura A; Tomita R; Sento S; Kitamura N; Yamamoto T
PLoS One; 2017; 12(11):e0188965. PubMed ID: 29190834
[TBL] [Abstract][Full Text] [Related]
28. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
[TBL] [Abstract][Full Text] [Related]
29. ASC contributes to metastasis of oral cavity squamous cell carcinoma.
Wu CS; Chang KP; OuYang CN; Kao HK; Hsueh C; Chen LC; Cheng HY; Liang Y; Liou W; Liang CL; Chang YS
Oncotarget; 2016 Aug; 7(31):50074-50085. PubMed ID: 27367024
[TBL] [Abstract][Full Text] [Related]
30. Association of Notch4 with metastasis in human oral squamous cell carcinoma.
Mk H; Prince S; Mohan AM; Krishnan KV; Devi A
Life Sci; 2016 Jul; 156():38-46. PubMed ID: 27197026
[TBL] [Abstract][Full Text] [Related]
31. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
[TBL] [Abstract][Full Text] [Related]
32. Expression of beta2-adrenergic receptor in oral squamous cell carcinoma.
Shang ZJ; Liu K; Liang DF
J Oral Pathol Med; 2009 Apr; 38(4):371-6. PubMed ID: 19141064
[TBL] [Abstract][Full Text] [Related]
33. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
Erdem NF; Carlson ER; Gerard DA; Ichiki AT
J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
[TBL] [Abstract][Full Text] [Related]
34. LINC00657 promotes malignant progression of oral squamous cell carcinoma via regulating microRNA-150.
Xu FY; Xu X; Hu XD
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2482-2490. PubMed ID: 32196599
[TBL] [Abstract][Full Text] [Related]
35. [Expression of voltage-gated potassium channel Kv3.4 in oral squamous cell carcinoma].
Wang R; Cai B; Xiang J; Zhu X; Jiang Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2016 Mar; 51(3):137-42. PubMed ID: 26980650
[TBL] [Abstract][Full Text] [Related]
36. microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.
Wang L; Liu H
Tumour Biol; 2016 Mar; 37(3):4105-13. PubMed ID: 26490981
[TBL] [Abstract][Full Text] [Related]
37. Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells.
Li X; Ding R; Han Z; Ma Z; Wang Y
Biomed Pharmacother; 2017 Dec; 96():434-442. PubMed ID: 29031202
[TBL] [Abstract][Full Text] [Related]
38. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
39. [Expression of Prion protein and its clinical significance in oral squamous cells carcinoma and oral leukoplakia].
Zhang J; Zeng Y; Zheng J; Xu J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Dec; 48(12):752-4. PubMed ID: 24495728
[TBL] [Abstract][Full Text] [Related]
40. γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma.
Cheng JC; Chiang MT; Lee CH; Liu SY; Chiu KC; Chou YT; Huang RY; Huang SM; Shieh YS
J Dent Res; 2016 Apr; 95(4):439-45. PubMed ID: 26661712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
